Evidence map›Paper›PMID 29769554›Full record

Trial reportScientific reports2018

Long term extension of a randomised controlled trial of probiotics using electronic health records.

Gareth Davies, Sue Jordan, Caroline J Brooks, Daniel Thayer, Melanie Storey, Gareth Morgan, Stephen Allen, Iveta Garaiova, Sue Plummer, Mike Gravenor

Open access · goldAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Scientific reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 3 pooled it
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 3 syntheses or guidelines pooled it, 30 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Trial
  6. Trial
  7. Trial
  8. Trial
  9. Review
  10. Review
  11. Paediatrics & child health · 2022
    Review
  12. Paediatrics & child health · 2022
    Review
  13. Review
  14. Review
  15. Review
  16. Article
  17. Review
  18. The Human Microbiota and Asthma.Clinical reviews in allergy & immunology · 2019
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Gareth DaviesSwansea University Medical School, Singleton Park, Swansea, UK.ORCID 0000-0001-9005-1618
Sue JordanDepartment of Nursing, The College of Human and Health Sciences, Swansea University, Singleton Park, Swansea, UK. S.E.Jordan@swansea.ac.uk.ORCID 0000-0002-5691-2987
Caroline J BrooksSwansea University Medical School, Singleton Park, Swansea, UK.
Daniel ThayerSwansea University Medical School, Singleton Park, Swansea, UK.
Melanie StoreyDepartment of Nursing, The College of Human and Health Sciences, Swansea University, Singleton Park, Swansea, UK.
Gareth MorganThe Children's Trust, Tadworth, Surrey, UK.
Stephen AllenLiverpool School of Tropical Medicine, Pembroke Place, Liverpool, UK.
Iveta GaraiovaResearch Department, Cultech Limited, Baglan Industrial Park, Port Talbot, UK.
Sue PlummerResearch Department, Cultech Limited, Baglan Industrial Park, Port Talbot, UK.
Mike GravenorSwansea University Medical School, Singleton Park, Swansea, UK.
Swansea University · GBCultech (United Kingdom) · GBLiverpool School of Tropical Medicine · GBLondon Clinic · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Most randomised controlled trials (RCTs) are relatively short term and, due to costs and available resources, have limited opportunity to be re-visited or extended. There is no guarantee that effects of treatments remain unchanged beyond the study. Here, we illustrate the feasibility, benefits and cost-effectiveness of enriching standard trial design with electronic follow up. We completed a 5-year electronic follow up of a RCT investigating the impact of probiotics on asthma and eczema in children born 2005-2007, with traditional fieldwork follow up to two years. Participants and trial outcomes were identified and analysed after five years using secure, routine, anonymised, person-based electronic health service databanks. At two years, we identified 93% of participants and compared fieldwork with electronic health records, highlighting areas of agreement and disagreement. Retention of children from lower socio-economic groups was improved, reducing volunteer bias. At 5 years we identified a reduced 82% of participants. These data allowed the trial's first robust analysis of asthma endpoints. We found no indication that probiotic supplementation to pregnant mothers and infants protected against asthma or eczema at 5 years. Continued longer-term follow up is technically straightforward.

Indexed as

AsthmaChild, PreschoolDouble-Blind MethodEczemaElectronic Health RecordsFemaleHumansInfant, NewbornMothersPregnancyProbioticsQuality of Life

Identifiers

PMID29769554
PMCPMC5955897
OpenAlexW2803370561

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.